Donor cell chimerism evaluation in cerebrospinal fluid by short tandem repeat analysis following allogeneic hematopoietic stem cell transplantation

Hum Immunol. 2018 Jul;79(7):537-538. doi: 10.1016/j.humimm.2018.04.001. Epub 2018 Apr 11.

Abstract

Cerebrospinal fluid (CSF) cell count, morphology and flow cytometric evaluations are used to investigate central nervous system (CNS) involvement in leukemia/lymphoma. We performed CSF short tandem repeat (STR) analysis to monitor CSF chimerism status and evaluate for disease involvement in 11 asymptomatic pediatric allogeneic hematopoietic stem cell transplantation (HSCT) recipients with hemato-lymphoid neoplasms and high risk for or history of CNS involvement. Eighteen (64%) of the samples with median CSF cell count of 1/mm3 with 90% lymphocytes gave conclusive STR results, suggesting that this DNA-based method can be used in monitoring CSF chimerism status after HSCT with an acceptable yield.

Keywords: Cerebrospinal fluid; Donor chimerism; Hematopoietic stem cell transplantation; Short tandem repeat analysis.

MeSH terms

  • Cerebrospinal Fluid / cytology*
  • Cerebrospinal Fluid / metabolism
  • Child
  • Chimerism
  • Female
  • Hematologic Neoplasms / immunology*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphocyte Count
  • Lymphocytes / pathology*
  • Male
  • Microsatellite Repeats / genetics*
  • Transplantation Chimera
  • Transplantation Conditioning
  • Transplantation, Homologous